A detailed history of Reap Financial Group, LLC transactions in Sanofi stock. As of the latest transaction made, Reap Financial Group, LLC holds 50 shares of SNY stock, worth $2,707. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 50 -0.0%
Holding current value
$2,707
Previous $2.88 Million 16.31%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Feb 27, 2025

BUY
$48.54 - $58.53 $2,427 - $2,926
50 New
50 $2.88 Million
Q1 2024

Feb 27, 2025

SELL
$45.75 - $52.48 $7,960 - $9,131
-174 Closed
0 $0
Q4 2023

Feb 27, 2025

BUY
$43.13 - $54.79 $7,504 - $9,533
174 New
174 $8.65 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $136B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Reap Financial Group, LLC Portfolio

Follow Reap Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reap Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reap Financial Group, LLC with notifications on news.